Sjogrens-Disease.com

The Coordination Burden in Multisystem Autoimmune Disease

Reviewed by: HU Medical Review Board | Last reviewed: August 2026 | Last updated: August 2026

Key Takeaways:

  • Comorbidity is the rule in Sjögren's disease: Among 994 surveyed patients, 49% also reported rheumatoid arthritis and 34% lupus, alongside high rates of allergies, hypertension, anxiety, and reflux.
  • Ninety percent identified a doctor, nurse, or other provider as someone they use to learn about or manage their health – yet 36% reported high worry about getting the medications and treatments they need.
  • Patients describe relaying information between specialists who do not communicate with each other, a coordinating role that defaults to them when no clinician holds it.

A patient with Sjögren's disease is rarely managed by one clinician. Glandular, ocular, oral, articular, and systemic features distribute across specialties by necessity, and the resulting care involves rheumatology, ophthalmology, dentistry, and primary care at minimum. Coordination across those hands is a clinical function. The question this raises is not whether it is being done well, but whether anyone has been assigned to do it – because when it is unassigned, the person who absorbs it is the patient.

A cohort with many diagnoses

Among 994 patients diagnosed with Sjögren's in the 2026 Sjögren's In America survey, the co-reported condition load is substantial, and it extends well beyond rheumatology. Patients reported the following other conditions:1

  • Chronic dry eye – 78%
  • Allergies – 62%
  • Chronic pain – 60%
  • Osteoarthritis – 52%
  • Hypertension – 51%
  • Anxiety – 50%
  • Gastroesophageal reflux disease – 50%
  • Rheumatoid arthritis – 49%
  • Cataracts – 44%
  • Fibromyalgia – 43%
  • Hyperlipidemia – 41%
  • Raynaud's syndrome – 39%
  • Major depressive disorder – 38%
  • Lupus – 34%

That distribution matters for how the coordination problem is framed. The overlapping autoimmune diagnoses are the ones a rheumatologist expects to manage. The rest – allergy, hypertension, reflux, cataract, lipids, mood – sit with clinicians who may never speak to each other about this patient. This cohort had a mean age of 63 and was 95% female, so some of that load reflects age rather than disease.1

Patients place clinicians at the center of managing all of it. Ninety percent identified a doctor, nurse, or healthcare provider as someone they currently use to learn about or manage their health – the most-selected option in the survey, ahead of general internet searches at 67% and condition-specific websites at 56%.1

Alongside that reliance sits measurable concern about reaching care:1

  • 36% reported high worry about getting the medications and treatments they need
  • 31% about getting access to doctors and specialists
  • Both measured as the top 2 points on a 1 to 7 “Not At All” to “A Lot” scale

Who is not being seen?

Utilization data shows how many hands are involved before comorbidity is even counted. A 2007 US mail survey compared 277 patients with 606 controls, having deliberately eliminated anyone self-reporting rheumatoid arthritis, lupus, mixed connective tissue disease, myositis, or scleroderma from both groups.2

Even in that screened population, 94% had seen a rheumatologist against 13% of controls, 79% an ophthalmologist against 51%, and 49% a neurologist against 16%. Patients took a mean of 6.7 prescription and over-the-counter medications against 2.5, and 53% had been hospitalized in the prior 5 years against 40%.2

That is the baseline multi-specialty load in uncomplicated disease. The surveyed cohort described above carries the comorbidities this study screened out.

The gap appears where follow-through is expected but unowned. Ocular and dental care are core to Sjögren's management, yet in a French national claims analysis of patients with Sjögren's, the proportion consulting either a dentist or an ophthalmologist in a given year ranged from roughly 23% in 2011 to roughly 50% in 2018 – fewer than half in any year studied, averaging 2 dental and 1 ophthalmologic reimbursement per patient annually. That is a non-US health system, but it quantifies something the patient-facing data describes qualitatively.3

In a 5-country qualitative study, patients identified insufficient time with clinical staff during visits in 4 of the 5 countries, and in all 5 they named not being taken seriously or understood by health personnel, difficulty obtaining a diagnosis, and the financial burden of the disease.4

In 3 countries, patients said long travel distances and waiting times actively inhibited regular visits. The authors' conclusion is a workforce argument built from patient data: Current visit lengths appear too short from the patient's point of view, and new models of care may be needed.4

The open-ended survey responses describe what fills the gap. One respondent wrote that finding a provider able to handle multiple autoimmune conditions was the central difficulty, and that seeing 3 separate providers who "usually don't talk to each other" meant "I have to be the go-between.”1

Another described specialists who "all only communicate through me," with a primary care physician not involved in managing their care at all.1

Assigning the coordinating role

The practical question is narrow: In this patient's chart, who owns the ocular and dental referral loop, and who reconciles the medication list across the prescribers involved? Naming that clinician explicitly – and telling the patient who it is – converts coordination from a default obligation into an assigned one.

Where the answer is rheumatology, the visit can carry a standing check on whether ocular and dental follow-up actually happened rather than whether it was recommended. Where it is primary care, that needs to be stated rather than assumed, since patients in these data describe primary care as frequently uninvolved.